These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1458931)

  • 21. Renal involvement in systemic lupud erythematosus (SLE): a study of 56 patients emphasizing histologic classification.
    Appel GB; Silva FG; Pirani CL; Meltzer JI; Estes D
    Medicine (Baltimore); 1978 Sep; 57(5):371-410. PubMed ID: 682942
    [No Abstract]   [Full Text] [Related]  

  • 22. IgM anti-β2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus.
    Mehrani T; Petri M
    J Rheumatol; 2011 Mar; 38(3):450-3. PubMed ID: 21123325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular complications in lupus nephritis and lupus-like syndromes.
    Seshan SV
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):687-91. PubMed ID: 11020958
    [No Abstract]   [Full Text] [Related]  

  • 24. Prognosis of systemic lupus erythematosus and the factors that affect it.
    Gladman DD
    Curr Opin Rheumatol; 1991 Oct; 3(5):789-96. PubMed ID: 1751311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of lupus nephritis in a patient with previous scleroderma renal crisis.
    McConville E; Smith D; Bélanger E; Ivory C
    Lupus; 2018 Sep; 27(10):1732-1734. PubMed ID: 30028255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Renal biopsy in the anatomo-clinical evaluation of lupus nephropathy].
    Monga G; Mazzucco G; Coppo R; Piccoli G
    Recenti Prog Med; 1978 Nov; 65(5):421-39. PubMed ID: 366687
    [No Abstract]   [Full Text] [Related]  

  • 27. Classifying lupus nephritis: a 32-year-old woman with systemic lupus erythematosus and nephritic syndrome.
    Bruijn JA; Verburgh CA; Huizinga TW
    Am J Kidney Dis; 2001 Mar; 37(3):653-7. PubMed ID: 11228195
    [No Abstract]   [Full Text] [Related]  

  • 28. The clinical course of the proliferative and membranous forms of lupus nephritis.
    Baldwin DS; Lowenstein J; Rothfield NF; Gallo G; McCluskey RT
    Ann Intern Med; 1970 Dec; 73(6):929-42. PubMed ID: 4947941
    [No Abstract]   [Full Text] [Related]  

  • 29. Vascular lesions in lupus nephritis.
    Grishman E; Venkataseshan VS
    Mod Pathol; 1988 May; 1(3):235-41. PubMed ID: 3237704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal vascular lesions in systemic lupus erythematosus.
    Katz SM; Korn S; Umlas SL; DeHoratius RJ
    Ann Clin Lab Sci; 1990; 20(2):147-53. PubMed ID: 2327730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lupus kidney and immunosuppressive agents].
    Huriet C
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):407-10. PubMed ID: 5510736
    [No Abstract]   [Full Text] [Related]  

  • 32. [Systemic lupus and kidney disease: contribution of anti-SSA].
    Baline K; Zaher K; Fellah H; Benchikhi H
    Pan Afr Med J; 2015; 20():39. PubMed ID: 26029328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staphylococcal scalded skin syndrome in the course of lupus nephritis.
    Rydzewska-Rosołowska A; Brzosko S; Borawski J; Myśliwiec M
    Nephrology (Carlton); 2008 Jun; 13(3):265-6. PubMed ID: 18315709
    [No Abstract]   [Full Text] [Related]  

  • 34. Renal transplantation for systemic lupus erythematosus and recurrent lupus nephritis.
    Uchida H; Sugimoto H; Nishimura Y; Ogawa N; Funamoto S; Degawa H; Ichikawa N; Andoh Y; Kikuchi K; Meigata K; Nomura Y; Bekku Y; Tomikawa S; Ohtsubo O
    Transplant Proc; 1998 Nov; 30(7):3908-9. PubMed ID: 9838710
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical findings and prognosis of kidney manifestations in systemic lupus erythematosus].
    Hartl W; Roos R; Genth E
    Klin Wochenschr; 1970 Jun; 48(12):711-23. PubMed ID: 5524893
    [No Abstract]   [Full Text] [Related]  

  • 36. [Renal manifestations in lupus].
    Dequiedt P
    Lille Med; 1978 Feb; 23(2):106-9. PubMed ID: 651538
    [No Abstract]   [Full Text] [Related]  

  • 37. Progression of mesangial and focal to diffuse lupus nephritis.
    Ginzler EM; Nicastri AD; Chen CK; Friedman EA; Diamond HS; Kaplan D
    N Engl J Med; 1974 Oct; 291(14):693-6. PubMed ID: 4604972
    [No Abstract]   [Full Text] [Related]  

  • 38. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.
    Wakasugi D; Gono T; Kawaguchi Y; Hara M; Koseki Y; Katsumata Y; Hanaoka M; Yamanaka H
    J Rheumatol; 2012 Jan; 39(1):79-85. PubMed ID: 22089455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use and interpretation of renal biopsy.
    Striker GE; Quadracci LJ; Cutler RE
    Major Probl Pathol; 1978; 8():1-339. PubMed ID: 24154
    [No Abstract]   [Full Text] [Related]  

  • 40. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: I. Damage to important organs whose early treatment makes a big difference; 4. Kidney].
    Hiromura K
    Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2558-66. PubMed ID: 24400535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.